We also found that higher levels of GAS6 and clinical biomarkers, including NT-proBNP, TnT, BUN and CRP, were accompanied by highest mortality in AHF patients, especially in those with renal dysfunction. This evidence concerns the gene GAS6 and Abnormal renal physiology.